| Course | PA 522 Comprehensive Clinical Module Endocrinology |
|---|---|
| Week | 6 |
| Paper type | Assay interference brief |
| Length | About 700 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | Master of Physician Assistant Studies (MPAS) |
| Updated | October 2026 |
Free sample paper for PA 522 Week 6
Assay Interference Brief: A TSH of 0.03 and a Free T4 of 2.9 in a Patient With a Pulse of 66 and No Tremor, and the 10 mg Biotin Supplement That Pushes Both Values the Wrong Way
Student Name
Chamberlain University
PA 522: Comprehensive Clinical Module Endocrinology
Instructor Name
Month Day, Year
Assay Interference Brief: A TSH of 0.03 and a Free T4 of 2.9 in a Patient With a Pulse of 66 and No Tremor, and the 10 mg Biotin Supplement That Pushes Both Values the Wrong Way
The Discordance
TSH 0.03 mIU/L (interval 0.4 to 4.0) and free T4 2.9 ng/dL (interval 0.8 to 1.8), drawn at the preoperative visit for adrenal vein sampling. On the same day M.T. had a pulse of 66, no tremor, no heat intolerance, stable weight and no eye signs. A TSH receptor antibody test, added by the laboratory, came back positive. The figures say marked hyperthyroidism with Graves disease; the patient shows none of it.
Candidate Mechanisms, Each With a Direction
Biotin: M.T. takes a 10 mg biotin supplement daily for brittle nails, about 300 times the daily requirement. Many immunoassays use a streptavidin and biotin step. In sandwich assays, used for TSH, excess biotin blocks the signal and gives a falsely low result. In competitive assays, the format used for free T4, total T3 and the receptor antibody test on this platform, it gives a falsely high result. A controlled study in healthy adults taking 10 mg of biotin a day showed exactly this pattern on affected platforms (Li et al., 2017). Direction: TSH down, free T4 up, receptor antibody up, the full false picture of Graves disease.
Heterophile antibodies: antibodies in the patient's blood that bind the assay's animal antibodies. These usually cause a falsely high result in sandwich assays, so they would more likely raise TSH than lower it. Direction: does not fit.
Binding protein changes: inherited or drug-related changes in the proteins that carry T4 can make some free T4 methods read high, but they do not lower TSH. Direction: fits only the T4 half.
Falsely High Is Not High
Throughout this brief, M.T.'s free T4 is called falsely high, not high, and the TSH falsely low, not suppressed, until confirmed. Writing "suppressed TSH" in the chart would invite a diagnosis of hyperthyroidism that may not exist and could lead to an antithyroid drug or radioactive iodine for a laboratory artifact.
Name the Confirmation
Stop biotin and repeat the thyroid panel and receptor antibody after at least 72 hours, longer than the 8 to 24 hours often quoted, because 10 mg is a high dose. At the same time, ask the laboratory whether the repeat can be run on a platform that does not use a biotin step. The laboratory confirmed that its platform is biotin-sensitive and that the manufacturer's insert lists interference above a set biotin concentration.
Allow That It Might Be True
Biotin explains the pattern, but it does not exclude real thyroid disease. If the repeat after stopping biotin still shows a low TSH and a high free T4, the result should be treated as true, and the usual workup follows: a repeat with total T3, a radioactive iodine uptake if appropriate, and a thyroid examination. The clinical picture, a calm patient with a normal pulse, makes true hyperthyroidism of this degree unlikely but not impossible, particularly in an older adult in whom symptoms can be mild.
Why It Matters Before Sampling
Hyperthyroidism raises the heart rate and can complicate procedures and anesthesia, and an iodinated contrast load during adrenal vein sampling can worsen true hyperthyroidism. The sampling date was held until the repeat thyroid tests were back, since the guideline places sampling in the hands of an experienced center working from a settled clinical picture (Funder et al., 2016).
Record and Prevention
The supplement is recorded in M.T.'s medication list as biotin 10 mg daily, so that every future immunoassay can be interpreted with it in mind. The clinic's intake form will now ask about biotin and hair, skin and nail supplements, since the study that showed this interference also showed how ordinary supplement doses produce it (Li et al., 2017).
References
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F., Jr. (2016). The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 101(5), 1889-1916. https://doi.org/10.1210/jc.2015-4061
Li, D., Radulescu, A., Shrestha, R. T., Root, M., Karger, A. B., Killeen, A. A., Hodges, J. S., Fan, S.-L., Ferguson, A., Garg, U., Sokoll, L. J., & Burmeister, L. A. (2017). Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA, 318(12), 1150-1160. https://doi.org/10.1001/jama.2017.13705
PA 522 Week 6 instructions, in plain terms
Week six asks for a brief on a laboratory result that disagrees with the clinical picture. Open with the discordance stated concretely: the values with their intervals and the clinical findings that do not match. Then give a small set of candidate mechanisms, each with the direction in which it would push each result, since different interferences move values in different directions. Keep the wording precise throughout, calling a result falsely high or falsely low until it is confirmed, not simply high or low. Name the confirmation step: what to stop, how long to wait, what to repeat and whether a different method is needed. Allow that the result might be true and say what would follow if so. Note any decision that should wait for the answer. Use short headed blocks and cite evidence for the mechanism.
Inside the PA 522 Week 6 example
The brief opens with TSH 0.03, free T4 2.9 and a positive receptor antibody against a pulse of 66, no tremor and stable weight, found at the preoperative visit. Three mechanisms follow with directions: biotin lowering sandwich-assay TSH and raising competitive-assay free T4, T3 and antibody, citing Li and colleagues' study of 10 mg doses; heterophile antibodies, which usually raise TSH and so do not fit; and binding protein changes, which fit only the T4 half. A section explains the falsely high wording and the risk of treating an artifact. The confirmation block sets a repeat after at least 72 hours and a check of the platform. A section allows true hyperthyroidism and names the workup. Sampling is held for contrast and heart rate reasons, and the supplement is added to the medication list.
PA 522 Week 6 rubric: what full points look like
Credit on this interference brief starts with a concrete statement of the discordance; a vague sense that results seem odd loses the most. Next in weight is the direction attached to each mechanism, since a mechanism that would push a value the wrong way should be excluded, and faculty check this reasoning closely. Credit is given for consistent wording that keeps the possibility of artifact visible. The confirmation step must be specific about what to stop, the waiting time and the repeat. A brief that dismisses the result entirely, without allowing it might be true, is marked down. Faculty also look for awareness of any pending decision the answer affects. Short headed blocks and a cited study of the interference complete the expected format.
PA 522 Week 6 help: mistakes that cost points
The common error in interference briefs is naming the interfering substance without explaining which way it moves each value. Send your discordant results and the patient's medicines and supplements, and a brief prepared for you would state the discordance in figures, give each plausible mechanism its direction and rule out the ones that point the wrong way. Wording keeps falsely high and falsely low distinct from confirmed results. The confirmation block is set out with a realistic waiting time and repeat plan. The brief also allows the result to be true and names the next steps if it is. If your case involves a different interference, such as macroprolactin or heterophile antibodies, the same structure is used. Check your laboratory's platform and guidance before relying on any timing.
Get a PA-522 Week 6 example written to your instructions
Send the discordant result, whatever clinical detail the assignment supplies and the instructions themselves, and a custom PA-522 Week 6 brief is built around your figures and returned inside 24 to 48 hours, the first one free. If your section names the assay platform or supplies a laboratory handout on interference, include it, because the plausible mechanisms shift with the method in use.
More PA 522 papers and MPAS samples
- PA 522 Week 1: Hormone Pair Discussion Post
- PA 522 Week 2: Feedback Axis Explainer
- PA 522 Week 3: Paired Hormone Interpretation
- PA 522 Week 4: Captopril Challenge Set
- PA 522 Week 5: Axis Level Write-Up
- PA 522 Week 7: Incidental Nodule Workup
- PA 522 Week 8: Monitoring Interval Rationale
- PA 520 Week 6: Dyspnea Scale Documentation
- PA 518 Week 6: Stress Test Selection Rationale
- PA 516 Week 6: Referred Ear Pain Map
- PA 514 Week 6: Antibiogram Reading Exercise
PA 522 Week 6 questions, answered
My assignment does not say which assay platform was used. Can the brief still work?
Yes, by arguing conditionally. The sample names the mechanisms that apply broadly, then marks the ones whose plausibility depends on the method and states what would need to be known. That conditional structure usually scores better than a confident answer resting on an unstated assumption. Attach any laboratory handout your classroom provides and the candidates narrow considerably.
How many candidate mechanisms should the brief carry?
Few enough that each one is argued and none is merely listed. Three well matched candidates with directions attached and a stated reason for their order beat eight names with nothing behind them. If your rubric specifies a number, that governs, and the sample meets it while keeping the direction and confirmation detail intact for every entry on the list.
Is this brief asking me to say what the clinician should do next?
It asks what the laboratory should do next, which is a different question and the one the module grades. The sample stays on confirming or refuting the figure: repeat, dilute, switch platform, measure a free fraction. Care decisions sit with your clinical faculty and with the reading your course has set, and nothing the desk writes steps over that line.
Where can I find a free PA 522 Week 6 sample paper?
The complete PA 522 Week 6 interference brief is on this page, explaining a low TSH and high free T4 in a calm patient by a 10 mg biotin supplement.
Why does the PA 522 Week 6 brief wait 72 hours before repeating the tests?
A 10 mg biotin dose is high, so the shorter waits often quoted may not clear enough of it to remove the interference from the assay.